tiprankstipranks
Advertisement
Advertisement

AU:CMB Stock Latest News

Regeneus Rectifies Late Substantial Shareholder Disclosure for Cambium Holdings
Company AnnouncementsRegeneus Rectifies Late Substantial Shareholder Disclosure for Cambium Holdings
21d ago
CMB
Regeneus Rectifies Late Substantial Shareholder Notice Filing
PremiumCompany Announcements
Regeneus Rectifies Late Substantial Shareholder Notice Filing
29d ago
CMB
Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular
PremiumCompany Announcements
Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular
3M ago
CMB
Cambium Bio Director Increases Stake Through Share Placement
PremiumCompany Announcements
Cambium Bio Director Increases Stake Through Share Placement
4M ago
CMB
Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance
PremiumCompany Announcements
Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance
4M ago
CMB
Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares
PremiumCompany AnnouncementsCambium Bio Seeks ASX Quotation for 4.36 Million New Shares
4M ago
CMB
Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions
Premium
Company Announcements
Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions
4M ago
CMB
Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows
Premium
Company Announcements
Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows
5M ago
CMB
Cambium Bio Plans Significant Share Placement to Raise Equity
PremiumCompany Announcements
Cambium Bio Plans Significant Share Placement to Raise Equity
5M ago
CMB
Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control
PremiumCompany Announcements
Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control
5M ago
CMB
Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular
PremiumCompany Announcements
Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular
6M ago
CMB
Cambium Bio Plans Share Placement to Raise Fresh Capital
PremiumCompany Announcements
Cambium Bio Plans Share Placement to Raise Fresh Capital
6M ago
CMB
Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials
PremiumCompany AnnouncementsCambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials
6M ago
CMB
Cambium Bio Advances with Strategic Partnerships and R&D Incentives
Premium
Company Announcements
Cambium Bio Advances with Strategic Partnerships and R&D Incentives
9M ago
CMB
Cambium Bio Corrects Director’s Interest Notice Date
Premium
Company Announcements
Cambium Bio Corrects Director’s Interest Notice Date
9M ago
CMB
Regeneus Ltd. Director Increases Stake with New Share Acquisition
PremiumCompany Announcements
Regeneus Ltd. Director Increases Stake with New Share Acquisition
9M ago
CMB
Regeneus Director Increases Stake with New Share Acquisition
PremiumCompany Announcements
Regeneus Director Increases Stake with New Share Acquisition
9M ago
CMB
Cambium Bio Limited Issues New Shares
PremiumCompany Announcements
Cambium Bio Limited Issues New Shares
9M ago
CMB
Cambium Bio Limited Announces Quotation of New Securities
PremiumCompany Announcements
Cambium Bio Limited Announces Quotation of New Securities
9M ago
CMB
Cambium Bio Limited Reports AGM Results with Notable ‘First Strike’
PremiumCompany AnnouncementsCambium Bio Limited Reports AGM Results with Notable ‘First Strike’
9M ago
CMB
Cambium Bio Limited Highlights Regenerative Medicine Advances at 2025 AGM
Premium
Company Announcements
Cambium Bio Limited Highlights Regenerative Medicine Advances at 2025 AGM
9M ago
CMB
Cambium Bio Partners with Locus Cell for Global Production of Elate Ocular® ABI
Premium
Company Announcements
Cambium Bio Partners with Locus Cell for Global Production of Elate Ocular® ABI
10M ago
CMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >